Ben R. Taylor, Chief Financial Officer of RECURSION PHARMACEUTICALS, INC. (NASDAQ:RXRX), sold 21,383 shares of Class A Common Stock at a price of $4.18 on December 29, 2025, according to a Form 4 ...
Hosted on MSN
Recursion Pharmaceuticals projects $100M synergies in 2025 amid advancing pipeline and partnerships
CEO Chris Gibson highlighted significant progress in 2024, including clinical data readouts from REC-617 and REC-994, which showed early efficacy signals and robust safety, respectively. REC-617, a ...
Condé Nast Traveler on MSN
The best city in the US for shopping is exactly the one you think it is
Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback